Abstract
We have recently documented variations in the level of N-ras gene amplification in independently passaged MCF-7 cells. To establish if these differences are due to a lack of genetic identity between current MCF-7 passages and the original cell line, we have performed karyological and restriction fragment length polymorphism (RFLP) analyses. Documentation of a combination of restriction fragment patterns which are characteristic of MCF-7 has been facilitated by an analysis of DNA from an early-passage of MCF-7 from the Michigan Cancer Foundation (MCF). In addition, such early passage cells and other MCF-7 lines also share a unique amplification of the N-ras oncogene. Using these criteria and karyotypic analysis it can be shown that a sample of MCF-7 obtained from the American Type Culture Collection (-ATCC) was derived from a different individual than was the original MCF-7 cell line. It is important that researchers verify the relationship of current cell lines to the original MCF-7. Furthermore, the techniques described here provide a powerful tool which may be used to assess the identity of cell stocks.
References
Soule HD, Vazquez J, Long A, Albert S, Brennan M: A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51: 1409–1413, 1973
Huesby R, Maloney T, McGrath CM: Evidence for a direct growth-stimulatory effect of estradiol on MCF-7 cellsin vivo. Cancer Res 44: 2654–2659, 1984
Graham KA, Richardson CL, Minden MD, Trent JM, Buick RN: Varying degrees of amplification of the N-ras oncogene in the human breast cancer cell line MCF-7. Cancer Res 45: 2201–2205, 1985
DeMartinville B, Wyman A, White K, Francke U: Assignment of the first highly polymorphic DNA marker locus to a human chromosome region. Cytogenet Cell Genet 32: 265, 1982
Donlon TA, Magenis RE: The use of Burkitt lymphoma cell lines with 8;14 translocations to further localize D14S1 on chromosome 14 byin situ hybridization. Cytogenet Cell Genet 37: 453–454, 1984
Wyman AR, White R: A highly polymorphic locus in human DNA. Proc Natl Acad Sci USA 77: 6754–6758, 1980
Shih C, Weinberg RA: Isolation of a transforming sequence from a bladder carcinoma cell line. Cell 29: 161–169, 1982
Barker D, White R: Characterization of two highly polymorphic loci on chromosome 11p. Cytogenet Cell Genet 37: 412–413, 1984
Goldfarb M, Shimizu K, Perucho M, Wigler M: Isolation and preliminary characterization of a human transforming gene from T24 bladder carcinoma cells. Nature 296: 404, 1982
Gusella J, Varsangi-Breiner A, Kao F, Jones C, Puck TT, Keys C, Orkin S, Housman D: Precise localization of the human β-globin gene complex on chromosome 11. Proc Natl Acad Sci USA 76: 5239–5243, 1979
Southern EM: Detection of specific sequences among DNA framents separated by gel electrophoresis. J Mol Biol 98: 503–517, 1975
Rigby PW, Dieckmann M, Rhodes C, Berg P: Labelling deoxyribonucleic acid to high specific activityin vitro by nick translation with DNA polymerase I. J Mol Biol 133: 237–251, 1977
Trent JM: Protocols of procedures and techniques in chromosome analysis of tumor stem cell cultures in soft agar. In: Salmon SE (ed): Cloning of Human Tumor Stem Cells. Alan R. Liss Publishing Inc, New York 1980, pp 345–349
Whang-Peng J, Lee EC, Kao-shan CS, Seibert K, Lippman M: Cytogenetic studies of human breast cancer cell lines: MCF-7 and derived variant sublines. J Natl Cancer Inst 71: 687–695, 1983
Botstein D, White RL, Skolnick M, Davis RW: Construction of a genetic linkage map in man using restriction fragment length polymorphisms. Am J Hum Genet 32: 314–331, 1980
O'Toole CM, Povey S, Hepburn P, Franks LM: Identity of some human bladder cell lines. Nature 301: 429–430, 1983
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Graham, K.A., Trent, J.M., Osborne, C.K. et al. The use of restriction fragment polymorphisms to identify the cell line MCF-7. Breast Cancer Res Tr 8, 29–34 (1986). https://doi.org/10.1007/BF01805922
Issue date:
DOI: https://doi.org/10.1007/BF01805922